Mammography screening: Are women really giving informed consent?

Journal of the National Cancer Institute

Volumn 95, Issue 20, 2003, Pages 1508-1511

  Baines, Cornelia J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EXAMINATION; CANCER CONTROL; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CLINICAL TRIAL; DATA ANALYSIS; DECISION MAKING; HEALTH CARE DELIVERY; HUMAN; INFORMED CONSENT; MAMMOGRAPHY; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK FACTOR; ADULT; AGE; AGED; BREAST TUMOR; CANADA; CONTROLLED CLINICAL TRIAL; FEAR; FEMALE; MASS SCREENING; MIDDLE AGED; MORTALITY; PSYCHOLOGICAL ASPECT; RADIOGRAPHY; STANDARD; STATISTICS; SURVIVAL; SURVIVAL RATE; SWEDEN; TIME;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CANADA; CONTROLLED CLINICAL TRIALS; FEAR; FEMALE; HUMANS; INFORMED CONSENT; MAMMOGRAPHY; MASS SCREENING; META-ANALYSIS; MIDDLE AGED; MORTALITY; STATISTICS; SURVIVAL ANALYSIS; SURVIVAL RATE; SWEDEN; TIME FACTORS;

EID: 0142054702     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djg026     Document Type: Article

References (36)

1. Cox B. Variation in the effectiveness of breast screening by year of follow-up. J Natl Cancer Inst Monogr 1997;(22):69-72.
2. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137(5 Part 1):347-60.
3. International Agency for Research on Cancer (IARC). IARC handbooks of cancer prevention. Vol 7. Breast cancer screening. Lyon (France): IARC Press; 2002. p 150.
4. Retsky M, Demicheli R, Hrushesky W. Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy. Breast Cancer Res Treat 2001;65:217-24.
5. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002;137(5 Part 1):305-12.
6. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000;92:1490-9.
7. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials [published erratum appears in Lancet 2002; 360:724]. Lancet 2002;359:909-19.
8. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34.
9. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988;297:943-8.
10. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991;18:49-56.
11. Shapiro S, Venet W, Strax P, Venet L. Mortality and case survival. Chapter 6. In: Periodic screening for breast cancer. The health insurance project and its sequelae 1963-1986. Baltimore (MD): Johns Hopkins University Press; 1988. p. 59-83.
12. Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-32.
13. Goodman SN. The mammography dilemma: a crisis for evidence-based medicine? Ann Intern Med 2002;137(5 Part 1):363-5.
14. Black WC, Nease RF Jr, Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995;87:720-31.
15. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years [published erratum appears in Can Med Assoc J 1993;148:718]. CMAJ 1992;147:1459-76.
16. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study: update on breast cancer mortality. J Natl Cancer Inst Monogr 1997;(22):37-41.
17. Taubes G. The breast-screening brawl [published erratum appears in Science 1997;276:1485]. Science 1997;275:1056-9.
18. Tabar L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF, et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2000; 38:625-51.
19. Ontario Breast Screening Program. Annual Report 2001/2002. Toronto, Ontario (Canada): Cancer Care Ontario; 2002. p. 35.
20. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years [published erratum appears in Can Med Assoc J 1993;148:718]. CMAJ 1992;147:1477-88.
21. Moss M. Blurred vision: doctors are weak link. The New York Times 2002 June 27; Sect. A:1.
22. Tabar L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001;91:1724-31.
23. Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 2002;95:458-69.
24. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003;361: 1405-10.
25. Baines CJ. The Canadian National Breast Screening Study: a perspective on criticisms. Ann Intern Med 1994;120:326-34.
26. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210.
27. Retsky M, Demicheli R, Hrushesky W. Breast cancer screening: controversies and future directions. Curr Opin Obstet Gynecol 2003;15:1-8.
28. Fisher B, Gunduz N, Coyle J, Rudock C, Saffer E. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res 1989;49:1996-2001.
29. Baum M, Chaplain MA, Anderson AR, Douek M, Vaidya JS. Does breast cancer exist in a state of chaos? Eur J Cancer 1999;35:886-91.
30. Demicheli R, Retsky MW, Swartzendruber DE, Bonadonna G. Proposal for a new model of breast cancer metastatic development. Ann Oncol 1997;8: 1075-80.
31. Fisher B. Laboratory and clinical research in breast cancer - a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res 1980; 40:3863-74.
32. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
33. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-28.
34. Pinedo HM, de Gruijl TD, van der Wall E, Buter J. Biological concepts of prolonged neoadjuvant treatment plus GM-CSF in locally advanced tumors. Oncologist 2000;5:497-500.
35. Brenner DJ, Sawant SG, Hande MP, Miller RC, Elliston CD, Fu Z, et al. Routine screening mammography: how important is the radiation-risk side of the benefit-risk equation? Int J Radiat Biol 2002;78:1065-7.
36. Moss S. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group. J Med Screen 1999;6:144-8.